University of Birmingham Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn’s disease

Citation for published version (Harvard): Sandborn, WJ, Feagan, BG, Loftus, EV, Peyrin-biroulet, L, Van Assche, G, D’haens, G, Schreiber, S, Colombel, J, Lewis, JD, Ghosh, S, Armuzzi, A, Scherl, E, Herfarth, H, Vitale, L, Mohamed, MF, Othman, AA, Zhou, Q, Huang, B, Thakkar, RB, Pangan, AL, Lacerda, AP & Panes, J 2020, 'Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn’s disease', Gastroenterology. https://doi.org/10.1053/j.gastro.2020.01.047